tiprankstipranks
Advertisement
Advertisement

DE:6MK Stock Latest News

Merck price target raised to $145 from $130 at UBS
The FlyMerck price target raised to $145 from $130 at UBS
2d ago
MRK
Merck, Daiichi Sankyo announces BLA for I-DXd granted priority review by FDA
PremiumThe Fly
Merck, Daiichi Sankyo announces BLA for I-DXd granted priority review by FDA
2d ago
MRK
Merck, Daiichi Sankyo granted priority review for ifinatamab deruxtecan BLA
PremiumThe Fly
Merck, Daiichi Sankyo granted priority review for ifinatamab deruxtecan BLA
2d ago
MRK
Merck begins tender offer to acquire Terns Pharmaceuticals
PremiumThe Fly
Merck begins tender offer to acquire Terns Pharmaceuticals
8d ago
MRK
TERN
Evaxion Biotech reports last patient visit in one-year extension of EVX-01 trial
PremiumThe Fly
Evaxion Biotech reports last patient visit in one-year extension of EVX-01 trial
8d ago
MRK
EVAX
Compugen initiated with a Buy at Lake Street
PremiumThe FlyCompugen initiated with a Buy at Lake Street
8d ago
AZN
MRK
Trump Trade: U.S. strengthens tariffs on steel, aluminum, copper imports
Premium
The Fly
Trump Trade: U.S. strengthens tariffs on steel, aluminum, copper imports
9d ago
AA
CI
Merck price target raised to $135 from $125 at JPMorgan
Premium
The Fly
Merck price target raised to $135 from $125 at JPMorgan
9d ago
MRK
White House says imposing tariffs on patented pharmaceutical products
PremiumThe Fly
White House says imposing tariffs on patented pharmaceutical products
12d ago
AZN
BMY
Trump Trade: President says Iran war will still take weeks
PremiumThe Fly
Trump Trade: President says Iran war will still take weeks
13d ago
AA
MT
Adagene announces results from the latest data cut of muzastotug study
PremiumThe Fly
Adagene announces results from the latest data cut of muzastotug study
13d ago
MRK
ADAG
Merck initiates Phase 2b/3 trial evaluating MK-8748
PremiumThe Fly
Merck initiates Phase 2b/3 trial evaluating MK-8748
13d ago
MRK
Merck’s Keytruda in combination approved in EU for ovarian carcinoma
PremiumThe FlyMerck’s Keytruda in combination approved in EU for ovarian carcinoma
13d ago
MRK
Trump administration readying new pharmaceutical tariffs, FT reports
Premium
The Fly
Trump administration readying new pharmaceutical tariffs, FT reports
13d ago
AZN
BMY
Trump Trade: U.S. not pulling assets from Strait of Hormuz yet
Premium
The Fly
Trump Trade: U.S. not pulling assets from Strait of Hormuz yet
15d ago
AZN
BMY
Drugmakers delay drug launch in Europe over U.S. pricing policies, Reuters says
PremiumThe Fly
Drugmakers delay drug launch in Europe over U.S. pricing policies, Reuters says
15d ago
AZN
BMY
Terns Pharmaceuticals downgraded to Hold from Buy at Truist
PremiumThe Fly
Terns Pharmaceuticals downgraded to Hold from Buy at Truist
15d ago
MRK
TERN
Merck announces results from CORALreef AddOn study of enlicitide decanoate
PremiumThe Fly
Merck announces results from CORALreef AddOn study of enlicitide decanoate
16d ago
MRK
Immix Biopharma completes NEXICART-2 enrollment, onboards CMO Richard Graydon
PremiumThe Fly
Immix Biopharma completes NEXICART-2 enrollment, onboards CMO Richard Graydon
16d ago
MRK
IMMX
Winrevair’s Mixed Phase 2 Signal Leaves Merck’s Risk‑Reward Balanced, Supporting a Hold Rating
PremiumRatingsWinrevair’s Mixed Phase 2 Signal Leaves Merck’s Risk‑Reward Balanced, Supporting a Hold Rating
16d ago
MRK
Merck announces data from Phase 2 Cadence trial of Winrevair
Premium
The Fly
Merck announces data from Phase 2 Cadence trial of Winrevair
17d ago
MRK
Wix downgraded, TripAdvisor upgraded: Wall Street’s top analyst calls
Premium
The Fly
Wix downgraded, TripAdvisor upgraded: Wall Street’s top analyst calls
19d ago
TW
AGX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >